Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell transplantation for peripheral T-cell lymphomas.

Esa Jantunen1, Francesco D'Amore

  • 1Department of Medicine, Kuopio University Hospital, Kuopio, Finland. esa.jantunen@kuh.fi

Leukemia & Lymphoma
|May 27, 2004
PubMed
Summary

High-dose therapy with stem cell transplantation (SCT) shows promise for peripheral T-cell lymphomas (PTCL). Further research, including international collaboration, is crucial for optimizing SCT strategies in these rare cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atmospheric mercury monitoring data across Italy: A multi-year national dataset (2020 - 2023).

Data in brief·2026
Same author

Survival in infants with trisomy 18, palliative care and ethical reflections: a single center considerations.

Italian journal of pediatrics·2026
Same author

Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases.

International journal of cancer·2025
Same author

Search for novel biomarkers of febrile neutropenia in hematological patients: an overview.

Clinical and experimental medicine·2025
Same author

Sepsis and mucositis-related biomarkers in adult hematologic patients with febrile neutropenia.

Leukemia & lymphoma·2025
Same author

Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies.

International journal of molecular sciences·2025

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Peripheral T-cell lymphomas (PTCL) are a diverse group of aggressive cancers with poor prognoses.
  • Novel therapeutic strategies are urgently needed for PTCL management.

Purpose of the Study:

  • To review the current evidence on the feasibility and efficacy of high-dose therapy supported by stem cell transplantation (SCT) in PTCL.
  • To identify areas for future research in SCT for PTCL.

Main Methods:

  • Systematic review of existing literature on autologous SCT (ASCT) and allogeneic SCT (allo-SCT) in PTCL.
  • Analysis of treatment outcomes in various PTCL subtypes.

Main Results:

  • ASCT outcomes in relapsed/refractory PTCL appear comparable to aggressive B-cell lymphomas.

Related Experiment Videos

  • Excellent results with ASCT in anaplastic large cell lymphoma (ALCL) warrant further validation.
  • Limited data exists for allo-SCT, but it holds potential due to graft-versus-lymphoma effects.

    • Conclusions:

    • High-dose therapy with SCT is a potential treatment modality for PTCL, particularly ASCT for certain subtypes.
    • Prospective trials are needed to confirm ASCT superiority and explore consolidation strategies for less favorable PTCL subtypes.
    • International collaboration is essential for advancing SCT research in rare PTCL due to limited patient numbers.